Hiroyuki Ito

8.3k total citations · 3 hit papers
225 papers, 5.2k citations indexed

About

Hiroyuki Ito is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Hiroyuki Ito has authored 225 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 172 papers in Pulmonary and Respiratory Medicine, 65 papers in Oncology and 41 papers in Surgery. Recurrent topics in Hiroyuki Ito's work include Lung Cancer Diagnosis and Treatment (128 papers), Lung Cancer Treatments and Mutations (122 papers) and Lung Cancer Research Studies (33 papers). Hiroyuki Ito is often cited by papers focused on Lung Cancer Diagnosis and Treatment (128 papers), Lung Cancer Treatments and Mutations (122 papers) and Lung Cancer Research Studies (33 papers). Hiroyuki Ito collaborates with scholars based in Japan, United States and Spain. Hiroyuki Ito's co-authors include Haruhiko Nakayama, Morihito Okada, Tomoyuki Yokose, Haruhiko Fukuda, Kenichi Nakamura, Kouzo Yamada, Masahiro Tsuboi, Norihiko Ikeda, Jiro Okami and Yohei Miyagi and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Hiroyuki Ito

203 papers receiving 5.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial

2022 764 citations Morihito Okada, Masahiro Tsuboi et al. profile →
Extended Clavien-Dindo classification of surgical complications: Japan Clinical Oncology Group postoperative complications criteria

2015 603 citations Hiroyuki Ito et al. profile →
LBA1 CheckMate 77T: Phase III study comparing neoadjuvant nivolumab (NIVO) plus chemotherapy (chemo) vs neoadjuvant placebo plus chemo followed by surgery and adjuvant NIVO or placebo for previously untreated, resectable stage II–IIIb NSCLC

2023 67 citations Tina Cascone, Mark M. Awad et al. Annals of Oncology profile →

Peers

Countries citing papers authored by Hiroyuki Ito

Since Specialization

Citations

This map shows the geographic impact of Hiroyuki Ito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroyuki Ito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroyuki Ito more than expected).

Fields of papers citing papers by Hiroyuki Ito

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroyuki Ito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroyuki Ito. The network helps show where Hiroyuki Ito may publish in the future.

Co-authorship network of co-authors of Hiroyuki Ito

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroyuki Ito. A scholar is included among the top collaborators of Hiroyuki Ito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroyuki Ito. Hiroyuki Ito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	LBA2 Clinical outcomes with perioperative nivolumab (NIVO) in patients (PTS) with resectable NSCLC from the phase III CheckMate 77T study 2024 ·ESMO Open ·Mark M. Awad, Tina Cascone, Jonathan Spicer, Jie He, Shun Lü, Fumihiro Tanaka, Robin Cornelissen, (unknown), (unknown), Luboš Petruželka, Lin Wu, J-L. Pujol, Hiroyuki Ito, T-E. Ciuleanu, (unknown), Annelies Janssens, C. Coronado Erdmann, Padma Sathyanarayana, S. Meadows–Shropshire, Mariano Provencio	2
2	Feasibility and comparative prognosis of segmentectomy versus lobectomy in centrally located small and solid dominant cN0 non–small cell lung cancer 2024 ·Journal of Thoracic and Cardiovascular Surgery ·Norifumi Tsubokawa, Takahiro Mimae, Akira Saeki, Yoshihiro Miyata, (unknown), Yujin Kudo, Takuya Nagashima, Hiroyuki Ito, Norihiko Ikeda, Morihito Okada	3
3	Preoperative predictors for recurrence sites associated with poor post-recurrence survival after surgery of non-small cell lung cancer: a multicenter study 2023 ·BMC Cancer ·Tetsuya Isaka, Hiroyuki Adachi, Kōtaro Murakami, (unknown), (unknown), (unknown), Yujin Kudo, Yoshihiro Miyata, Morihito Okada, Norihiko Ikeda, Hiroyuki Ito	1
4	LBA1 CheckMate 77T: Phase III study comparing neoadjuvant nivolumab (NIVO) plus chemotherapy (chemo) vs neoadjuvant placebo plus chemo followed by surgery and adjuvant NIVO or placebo for previously untreated, resectable stage II–IIIb NSCLC breakdown → 2023 ·Annals of Oncology ·Tina Cascone, Mark M. Awad, (unknown), Jie He, Shun Lü, Boris Sepesi, Fumihiro Tanaka, Janis M. Taube, Robin Cornelissen, Libor Havel, (unknown), Luboš Petruželka, Lin Wu, J-L. Pujol, Hiroyuki Ito, C. Coronado Erdmann, Padma Sathyanarayana, S. Meadows–Shropshire, (unknown)	67
5	Wedge resection is an acceptable treatment option for radiologically low-grade lung cancer with solid predominance 2023 ·Interdisciplinary CardioVascular and Thoracic Surgery ·(unknown), Takahiro Mimae, Norifumi Tsubokawa, Yoshihiro Miyata, Hiroyuki Adachi, Yoshihisa Shimada, Hiroyuki Ito, Norihiko Ikeda, Morihito Okada	3
6	Limited resection for stage IA radiologically invasive lung cancer: a real-world nationwide database study 2022 ·European Journal of Cardio-Thoracic Surgery ·Junichi Soh, Shinichi Toyooka, Yasushi Shintani, Jiro Okami, Hiroyuki Ito, Takashi Ohtsuka, Takeshi Mori, Shun‐ichi Watanabe, Hisao Asamura, Masayuki Chida, Shunsuke Endo, Ryoichi Nakanishi, Mitsutaka Kadokura, Hidemi Suzuki, Etsuo Miyaoka, Ichiro Yoshino, Hiroshi Date	22
7	Hazard Function Analysis of Recurrence in Patients with Curatively Resected Lung Cancer: Results from the Japanese Lung Cancer Registry in 2010 2022 ·Cancers ·Yoshikane Yamauchi, Masafumi Kawamura, Jiro Okami, Yasushi Shintani, Hiroyuki Ito, Takashi Ohtsuka, Shinichi Toyooka, Takeshi Mori, Shun‐ichi Watanabe, Hisao Asamura, Masayuki Chida, Shunsuke Endo, Mitsutaka Kadokura, Ryoichi Nakanishi, Etsuo Miyaoka, Hidemi Suzuki, Ichiro Yoshino, Hiroshi Date	0
8	The impact of epidermal growth factor receptor mutation status on adjuvant chemotherapy for patients with high-risk stage I lung adenocarcinoma 2022 ·Journal of Thoracic and Cardiovascular Surgery ·Yasuhiro Tsutani, Masaoki Ito, Yoshihisa Shimada, Hiroyuki Ito, Norihiko Ikeda, Haruhiko Nakayama, Morihito Okada	16
9	A Study on 77 Cases of Bell’s Palsy and 32 Cases of Ramsay Hunt Syndrome 2016 ·Practica Oto-Rhino-Laryngologica ·(unknown), Hiroyuki Ito, (unknown), Kiyoaki Tsukahara	2
10	Limited resection trial for pulmonary ground-glass opacity nodules: case selection based on high-resolution computed tomography--interim results 2015 ·Japanese Journal of Clinical Oncology ·Junji Yoshida, Genichiro Ishii, Tomoyuki Hishida, Keiju Aokage, Masahiro Tsuboi, Hiroyuki Ito, Tomoyuki Yokose, Haruhiko Nakayama, Kouzo Yamada, Kanji Nagai	25
11	Identification of Epstein-Barr Virus–Induced Gene 3 as a Novel Serum and Tissue Biomarker and a Therapeutic Target for Lung Cancer 2011 ·Clinical Cancer Research ·Ryohei Nishino, Atsushi Takano, (unknown), Nobuhisa Ishikawa, Hirohiko Akiyama, Hiroyuki Ito, Haruhiko Nakayama, Yohei Miyagi, Eiju Tsuchiya, Nobuoki Kohno, Yusuke Nakamura, Yataro Daigo	65
12	Wnt Inhibitor Dickkopf-1 as a Target for Passive Cancer Immunotherapy 2010 ·Cancer Research ·Nagato Sato, Takumi Yamabuki, Atsushi Takano, Junkichi Koinuma, Masato Aragaki, Ken Masuda, Nobuhisa Ishikawa, Nobuoki Kohno, Hiroyuki Ito, Masaki Miyamoto, Haruhiko Nakayama, Yohei Miyagi, Eiju Tsuchiya, Satoshi Kondo, Yusuke Nakamura, Yataro Daigo	129
13	Identification of Nectin-4 Oncoprotein as a Diagnostic and Therapeutic Target for Lung Cancer 2009 ·Cancer Research ·Atsushi Takano, Nobuhisa Ishikawa, Ryohei Nishino, Ken Masuda, Wataru Yasui, Kouki Inai, Hitoshi Nishimura, Hiroyuki Ito, Haruhiko Nakayama, Yohei Miyagi, Eiju Tsuchiya, Nobuoki Kohno, Yusuke Nakamura, Yataro Daigo	211
14	Cancer-Testis Antigen Lymphocyte Antigen 6 Complex Locus K Is a Serologic Biomarker and a Therapeutic Target for Lung and Esophageal Carcinomas 2007 ·Cancer Research ·Nobuhisa Ishikawa, Atsushi Takano, Wataru Yasui, Kouki Inai, Hitoshi Nishimura, Hiroyuki Ito, Yohei Miyagi, Haruhiko Nakayama, Masahiro Fujita, Masao Hosokawa, Eiju Tsuchiya, Nobuoki Kohno, Yusuke Nakamura, Yataro Daigo	107
15	D4-01: Correlation between high-resolution CT findings, histopathological and clinical findings of small pulmonary adenocarcinomas 2007 ·Journal of Thoracic Oncology ·Haruhiro Saito, Kouzo Yamada, Fumihiro Oshita, Yasufumi Kato, Hiroyuki Ito, Haruhiko Nakayama, Yoichi Kameda, Kazumasa Noda	1
16	Phase I Trial of Concurrent Chemoradiotherapy for Laryngeal and Hypopharyngeal Cancers with Bi-weekly Docetaxel 2005 ·Nihon Kikan Shokudoka Gakkai Kaiho ·Tomoyuki Yoshida, Kazuhiro Nakamura, (unknown), (unknown), Isaku Okamoto, Ryoji Tokashiki, Hiroyuki Ito, (unknown), (unknown), Daisuke Takata, Mamoru Suzuki	3
17	The Treatments of Esophageal Cancers of Multiple Primary Cancers Including the Esophageal Cancers and Head and Neck Cancers. 2001 ·Nihon Kikan Shokudoka Gakkai Kaiho ·Kiyoaki Tsukahara, Yasuhisa Koyanagi, Tomoyuki Yoshida, Hisashi Inoue, Hiroyuki Ito, Mamoru Suzuki	3
18	Enhanced Thin-Section Computed Tomography Helps Differentiate Malignant and Benign Small Solid Pulmonary Nodules. 2001 ·Haigan ·Mizuki Ikehara, Kozo Yamada, Haruhiro Saito, Fumihiro Oshita, Kazumasa Noda, Hiromasa Arai, Hiroyuki Ito, Haruhiko Nakayama, Aki Mitsuda, Yoichi Kameda	2
19	Chondroblastoma of Temporal Bone with Facial Palsy; A Case Report. 1992 ·Practica Oto-Rhino-Laryngologica ·Hisaya Tanaka, Kiyotaka Murata, Hiroki Kimura, Masahiro Ishikawa, Kaori Tanaka, Fumihiko Ohta, Hiroyuki Ito, Yoshinobu Nakamura	1
20	ECG Patterns and the Potential Field Profile on the Thoracic Surface of the Rat 1982 ·Shiko Chichibu, (unknown), Hiroyuki Ito, Kôzô Okamoto	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact